News and trends on diagnostics testing, insurance coverage, and reimbursement.
Cigna is the first national private payor to provider coverage for the Decipher tests, which provide a genomic assessment of tumor aggressiveness.
The tests have received coverage decisions from a number of Blue Cross Blue Shield plans this year including ones in California and New Jersey.
The Center for Genomic Interpretation and NSGC want payors to cover confirmatory testing for patients with positive results from 23andMe's FDA-cleared test.
TriCore's new president and CEO reflects on lab industry advancements and discusses new changes on the horizon.
The company said it has produced documents in response to the government's civil investigative demand notice.
